Literature DB >> 10586265

Abnormal Schwann cell-axon interactions in CMT neuropathies. The effects of mutant Schwann cells on the axonal cytoskeleton and regeneration-associated myelination.

Z Sahenk1.   

Abstract

Preferential distal axonal loss is a common feature of Charcot-Marie-Tooth (CMT) hereditary neuropathies. The general hypothesis tested here is that the axonal loss in these disorders is due to perturbed Schwann cell-axon interactions resulting from primary Schwann genetic defects. The nerve xenograft model was used to study the local influence of mutant Schwann cells derived from patients on axonal properties and the regeneration-associated myelination process. Sural nerve segments from individuals with PMP22 duplications or deletions and point mutations, as well as Cx32 point mutations were grafted into cut ends of the sciatic nerve of nude mice and studied at different time intervals after grafting. CMT1A and CMTX xenografts examined at 16 weeks show that the nude mouse axons within the proximal part of grafts demonstrate a significant increase in axonal area with an increase in the neurofilament and membranous organelle density compared to distal graft and distal host segments. A preferential distal axonal loss associated with a perpetual axonal atrophy, degeneration, and axonal sprouting was observed over time with increasing frequency at 8 to 16 weeks. A distal summation of the pathology, as evidenced by a greater amount of fiber loss in the distal graft segments, was present similar to that observed in patients. These alterations were seen to a lesser extent in PMP22 deletion or point mutation xenografts and were not observed in controls. Collectively, these findings show that Schwann cells bearing the PMP22 or Cx32 genetic defects cause major perturbations in Schwann cell-axon interactions emphasizing the role of axonal component in the pathogenesis of hereditary neuropathies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10586265

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

1.  N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom.

Authors:  L Kalaydjieva; D Gresham; R Gooding; L Heather; F Baas; R de Jonge; K Blechschmidt; D Angelicheva; D Chandler; P Worsley; A Rosenthal; R H King; P K Thomas
Journal:  Am J Hum Genet       Date:  2000-05-30       Impact factor: 11.025

Review 2.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

3.  Mutant HSPB1 overexpression in neurons is sufficient to cause age-related motor neuronopathy in mice.

Authors:  Amit K Srivastava; Samantha R Renusch; Nicole E Naiman; Shuping Gu; Amita Sneh; W David Arnold; Zarife Sahenk; Stephen J Kolb
Journal:  Neurobiol Dis       Date:  2012-04-11       Impact factor: 5.996

4.  Disruption of fibroblast growth factor receptor signaling in nonmyelinating Schwann cells causes sensory axonal neuropathy and impairment of thermal pain sensitivity.

Authors:  Miki Furusho; Jeffrey L Dupree; Melissa Bryant; Rashmi Bansal
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

Review 5.  The function of the Periaxin gene during nerve repair in a model of CMT4F.

Authors:  Anna C Williams; Peter J Brophy
Journal:  J Anat       Date:  2002-04       Impact factor: 2.610

6.  A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2L) maps to chromosome 12q24.

Authors:  Bei-Sha Tang; Wei Luo; Kun Xia; Jian-Feng Xiao; Hong Jiang; Lu Shen; Jian-Guang Tang; Guo-Hua Zhao; Fang Cai; Qian Pan; He-Ping Dai; Qi-Dong Yang; Jia-Hui Xia; Oleg V Evgrafov
Journal:  Hum Genet       Date:  2004-03-12       Impact factor: 4.132

Review 7.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

8.  AAV1.NT-3 gene therapy for charcot-marie-tooth neuropathy.

Authors:  Zarife Sahenk; Gloria Galloway; Kelly Reed Clark; Vinod Malik; Louise R Rodino-Klapac; Brian K Kaspar; Lei Chen; Cilwyn Braganza; Chrystal Montgomery; Jerry R Mendell
Journal:  Mol Ther       Date:  2013-10-28       Impact factor: 11.454

9.  CMTX Disorder and CamKinase.

Authors:  Frédéric Bihel; Burkhard Gess; Michel Fontés
Journal:  Front Cell Neurosci       Date:  2016-03-01       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.